SCHEMBL23012278

SCHEMBL23012278

O=C(Nc1ccc2oc(-c3ccnc(C(=O)N4CCN(C(c5ccccc5)c5nnn(C(F)F)n5)CC4)c3)nc2c1)[C@@H]1C[C@H]1F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.37
▸ SMN1; SMN2 Q16637 8/20 0.37
▸ KDM4E B2RXH2 7/20 0.37
▸ NPC1 O15118 7/20 0.37
▸ RAB9A P51151 7/20 0.37
▸ HPGD P15428 5/20 0.37
▸ NPSR1 Q6W5P4 2/20 0.36
▸ MAPT P10636 2/20 0.36
▸ RXFP1 Q9HBX9 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ TP53 P04637 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ POLB P06746 5/20 0.35
▸ HSD17B10 Q99714 2/20 0.35
▸ PPARG P37231 1/20 0.35
▸ NR2E3 Q9Y5X4 1/20 0.35
▸ NCOR2 Q9Y618 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28701705 1.00 ALDH1A1 (0.37) ALDH1A1SMN1; SMN2KDM4ENPC1RAB9A
SCHEMBL23012296 1.00 ALDH1A1 (0.37) ALDH1A1SMN1; SMN2KDM4ENPC1RAB9A
SCHEMBL28695312 1.00 ALDH1A1 (0.37) ALDH1A1SMN1; SMN2KDM4ENPC1RAB9A
SCHEMBL28713352 1.00 ALDH1A1 (0.37) ALDH1A1SMN1; SMN2KDM4ENPC1RAB9A
SCHEMBL23012351 1.00 ALDH1A1 (0.37) ALDH1A1SMN1; SMN2KDM4ENPC1RAB9A
SCHEMBL28713883 1.00 ALDH1A1 (0.37) ALDH1A1SMN1; SMN2KDM4ENPC1RAB9A
SCHEMBL23012084 0.95 MGLL (0.38) ALDH1A1SMN1; SMN2KDM4ENPC1RAB9A
SCHEMBL23012862 0.95 MGLL (0.38) ALDH1A1SMN1; SMN2KDM4ENPC1RAB9A
SCHEMBL23012112 0.92 NPC1 (0.42) ALDH1A1SMN1; SMN2KDM4ENPC1RAB9A
SCHEMBL29479650 0.92 NPC1 (0.42) ALDH1A1SMN1; SMN2KDM4ENPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114269725-B Anti-influenza virus compound, preparation method and application thereof 西藏海思科制药有限公司 2024-09-17 — — CN disclosed
US-20230079045-A1 ANTI-INFLUENZA VIRUS COMPOUND, PREPARATION METHOD AND USE THEREOF SICHUAN HAISCO PHARMACEUTICAL CO., LTD. (CN) 2023-03-16 — — US disclosed
CN-114269725-A Anti-influenza virus compound and preparation method and application thereof 四川海思科制药有限公司 2022-04-01 — — CN disclosed
WO-2021032209-A1 ANTI-INFLUENZA VIRUS COMPOUND, PREPARATION METHOD AND USE THEREOF 四川海思科制药有限公司 2021-02-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230079045-A1 ANTI-INFLUENZA VIRUS COMPOUND, PREPARATION METHOD AND USE THEREOF IDE, ACE, SI ALDH1A1 1085/4885SMN1; SMN2 4304/4885KDM4E 3910/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback